Curis (CRIS) Announces Full EMA CHMP Approval for Erivedge (RHHBY)
Tweet Send to a Friend
Curis, Inc. (Nasdaq: CRIS) announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE